Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADC Therapeutics SA Common Shares (NY:ADCT)

3.755 -0.205 (-5.18%)
Streaming Delayed Price Updated: 2:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADC Therapeutics SA Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
ADC Therapeutics Stock Is Plunging Today - What's Going On? ↗
ADC Therapeutics SA (NASDAQ: ADCT) has voluntarily paused enrollment of new patients in the Phase 2 LOTIS-9 trial evaluating Zynlonta (loncastuximab tesirine-lpyl) and rituximab (Lonca-R) in unfit or... 
Via Benzinga
News headline image
ADC Therapeutics Announces Voluntary Pause of Enrollment in the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients
From ADC Therapeutics SA
Via GlobeNewswire
News headline image
ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
Data being presented at the EHA 2023 Hybrid Congress will also be highlighted in an encore oral presentation at 17-ICML 
From ADC Therapeutics SA
Via GlobeNewswire
News headline image
Earnings Preview: ADC Therapeutics ↗
 
Via Benzinga
The Latest Analyst Ratings for ADC Therapeutics ↗
 
Via Benzinga
4 Analysts Have This to Say About ADC Therapeutics ↗
 
Via Benzinga
News headline image
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
From ADC Therapeutics SA
Via GlobeNewswire
News headline image
ADC Therapeutics Announces Updated Results from LOTIS-2 Trial to be Presented at the European Hematology Association 2023 Hybrid Congress
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023
From ADC Therapeutics SA
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023 ↗
 
Via Benzinga
News headline image
ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022
From ADC Therapeutics SA
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 74 companies achieved new lows for the year. 
Via Benzinga
News headline image
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
From ADC Therapeutics SA
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
News headline image
ADC Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics to Host Fourth Quarter and Year-End 2022 Financial Results Conference Call on February 28, 2023
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics to Participate in February Investor Conferences
From ADC Therapeutics SA
Via Business Wire
News headline image
Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity... 
Via Benzinga
News headline image
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer
From ADC Therapeutics SA
Via Business Wire
News headline image
Nike, FedEx And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday 
Via InvestorPlace
News headline image
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket ↗
Gainers ADC Therapeutics SA (NASDAQ: ADCT) shares rose 36.8% to $4.35 in pre-market trading. ADC Therapeutics and Sobi announced European Commission approval of ZYNLONTA for the treatment of relapsed... 
Via Benzinga
News headline image
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
From ADC Therapeutics SA
Via Business Wire
News headline image
ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer
From ADC Therapeutics SA
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.